Mounjaro Updates
This is an in-service training for the staff of CUHK Medical Centre
Educate on the pathophysiology of obesity, mode of actions of novel class of dual GIP/GLP1 receptor agonists, phase III clinical trial data including efficacy and safety of Tirzepatide for the use of T2DM and obese populations
CPE Point : 1 per event
Date:
2025-01-08
Time:
1:00pm to 2:00pm
Venue:
L3 Pharmacy Library, CUHKMC
Organising Institute:
CUHK Medical Centre
Speaker:
Stephanie Tan, Registered Dietitian, BSc (Hons), MSc, PgDip Nutrition, Members of Hong Kong Dietitians Association (HKDA)
Related CPE Activities:
